Goodsurance

Policy & oversight

Medicare Fraud Fugitive Caught Overseas With a Fake Passport After More Than Three Years on the Run

Khalid Satary, who allegedly billed Medicare more than 547 million dollars for medically unnecessary genetic tests, was arrested July 20 and is in United States custody after evading federal authorities for more than three years.

By the Goodsurance editorial teamJuly 30, 2026

Federal authorities announced the arrest of Khalid Satary, 54, in connection with one of the largest Medicare fraud cases ever charged by the Department of Justice. Satary was indicted in 2019 in the Eastern District of Louisiana on charges that his diagnostic testing laboratories billed Medicare for medically unnecessary cancer genetic tests from 2016 through 2019. The indictment alleged the scheme generated more than 547 million dollars in Medicare claims, with each test sample reimbursed at between 10,000 dollars and 20,000 dollars.

Prosecutors alleged that Satary used patient recruiters, offshore telemarketing call centers, and telemedicine companies to obtain test samples from Medicare beneficiaries through deceptive marketing campaigns and illegal kickbacks. Telemedicine physicians were paid to sign test orders without examining the patients whose Medicare numbers were billed.

A federal arrest warrant was issued in December 2022 after Satary failed to appear for a court hearing and allegedly fled the United States. The Department of Justice placed him on its Most Wanted Fraudsters list on June 23, 2026. On July 20, 2026, regional law enforcement partners apprehended him in the Middle East, where he was carrying a fake Mexican passport bearing a false name. He was subsequently transferred to United States custody.

The case demonstrates that Medicare fraud enforcement extends across international borders. Beneficiaries whose personal information was used in the scheme may have fraudulent test orders recorded under their Medicare numbers, which they can review through Medicare.gov.

In plain words

A man charged with cheating Medicare out of more than 547 million dollars has been caught. He was hiding in the Middle East under a fake name.

Khalid Satary ran labs accused of billing Medicare for expensive cancer gene tests that patients did not need. Each test could cost Medicare more than 10,000 dollars. His companies used phone calls and misleading ads to find patients, then paid doctors to approve the tests without properly reviewing whether patients needed them.

When he did not show up to court in 2022, he ran away. The Justice Department put him on its Most Wanted list in June 2026. Authorities found him on July 20, 2026, and brought him back to the United States.

Source: U.S. Department of Justice
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

OIG Found More Than 15 Million Dollars in Medicare Payments Where Emergency Room Billing Codes Were Used at Non-Emergency Sites

A March 2026 federal audit identified improper and potentially improper Medicare payments made when physicians and hospitals used emergency department billing codes for care not actually delivered in an emergency department, and found that Medicare lacked automated safeguards to catch the mismatches.

August 8, 2026

Policy & oversight

Federal Audit Found at Least 4.7 Million Dollars in Medicare Overpayments at an Arkansas Hospital

An OIG audit of Jefferson Regional Medical Center found a high rate of billing errors on claims flagged as elevated risk, producing an estimated 4.7 million dollars in improper Medicare payments. The hospital disputed most of the findings.

August 7, 2026

Policy & oversight

CMS Publishes Plan to Speed Medicare Coverage for Breakthrough Medical Devices

A new pathway would give FDA-cleared breakthrough devices a national Medicare coverage decision within weeks of regulatory approval, rather than waiting years under the standard process.

August 7, 2026

Policy & oversight

Federal Audit Found 97 Cybersecurity Gaps in Medicare Billing Contractors for Fiscal Year 2024, Though the Most Serious Deficiencies Declined

An OIG annual report to Congress found information security deficiencies across all seven Medicare administrative contractors in fiscal year 2024, while noting that high-risk and moderate-risk gaps fell compared with the prior year.

August 6, 2026

Policy & oversight

CMS Published Second-Quarter 2026 Drug Coding Decisions That Shape How Medicare Identifies and Pays for New Medicines

The quarterly HCPCS drug coding update, posted July 29 and highlighted in the August 6 MLN Connects newsletter, determines which new medications and biologicals get a dedicated Medicare billing code.

August 6, 2026

Policy & oversight

CMS Sets a Sunset Date for the NTAP Alternative Track for Breakthrough Devices and Advances the RAPID Pathway

The fiscal year 2027 hospital payment final rule phases out the alternative NTAP track that breakthrough-designated devices used to qualify for Medicare reimbursement, while a new CMS-FDA program called RAPID is positioned to take its place.

August 5, 2026